搜尋結果
2020年12月10日 · BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. The primary end points...
2023年9月11日 · Pfizer-BioNTech Fact Sheets Fact Sheet Translations Vacunas contra el COVID-19. On September 11, 2023, the Food and Drug Administration amended the emergency use authorization (EUA) of Pfizer...
2020年12月11日 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older. It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:
2022年11月18日 · The Secretary for Health has authorised the Comirnaty Original/Omicron BA.4-5 bivalent vaccine by Fosun Pharma/BioNTech for emergency use in Hong Kong, the Government announced today. According to the information provided by the drug manufacturer, the first batch of the Comirnaty bivalent vaccine to be supplied to Hong Kong is ...
The German company BioNTech partnered with Pfizer to develop and test a coronavirus vaccine known as BNT162b2, the generic name tozinameran or the brand name Comirnaty. A clinical trial...
2022年6月3日 · Overview. This vaccine resource provides key vaccine-specific information for the Pfizer-BioNTech COVID-19 Vaccine Comirnaty®, a messenger RNA (mRNA) based vaccine against coronavirus disease (COVID-19). This document has been updated in English: version 03 June 2022. WHO Team. WHO Headquarters (HQ) Editors. World Health Organization.
2021年3月11日 · Data suggest Pfizer-BioNTech vaccine prevents asymptomatic SARS-CoV-2 infection. Latest data analysis finds unvaccinated individuals were 44 times more likely to develop symptomatic COVID-19 and 29 times more likely to die from COVID-19.
